Company page

Agios Pharmaceuticals, Inc.

Agios Pharmaceuticals, Inc. is a public company traded under the ticker AGIO in the American market. The company has a market capitalization of approximately $2.16 billion. Agios focuses on developing innovative therapies for patients with genetically defined diseases and cancer.